7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing 
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026 
Dublin, Oct. 24, 2016 -- Research and Markets has announced the addition of the "Imaging Agents - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for Imaging Agents in US$ by the following Product Segments: Contrast Media (X-Ray/CT, MRI, & Ultrasound), and Diagnostic Radiopharmaceuticals. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
The report profiles 53 companies including many key and niche players such as
- Aytu BioScience, Inc. (US)
- Bayer Healthcare Pharmaceuticals (Germany)
- Bracco Diagnostics, Inc. (US)
- Daiichi Sankyo Company Limited (Japan)
- Eisai Co., Ltd. (Japan)
- Eli Lilly and Company (US)
- GE Healthcare (UK)
- Guerbet Group (France)
- Lantheus Medical Imaging, Inc. (US)
- Mallinckrodt plc (Ireland)
Key Topics Covered:
1. Industry Overview
2. Segmental Overview And Competitive Landscape
3. Market Trends & Issues
4. Global Medical Imaging Market - An Overview
5. Product Overview
6. Technology Dynamics
7. Product Launches/Approvals/ Clinical Trials
8. Recent Industry Activity
9. Focus On Select Players
10. Global Market Perspective
Total Companies Profiled: 53 (including Divisions/Subsidiaries 61)
- The United States (33)
- Canada (2)
- Japan (1)
- Europe (19)
- - France (3)
- - Germany (5)
- - The United Kingdom (2)
- - Italy (2)
- - Rest of Europe (7)
- Asia-Pacific (Excluding Japan) (5)
- Africa (1)
For more information about this report visit http://www.researchandmarkets.com/research/2mgfvc/imaging_agents
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Contrast Media
